GPT-Rosalind

Assess

Platforms

An OpenAI model for life sciences research tasks.

Why it's here

Placed in Assess: 1 article(s) of evidence from 1 source(s), led by model releases, with 1 in the last 30 days. Confidence 24%. Low accumulated evidence, so it defaults conservatively pending more signal.

Evidence (1)

6OpenAI Blog·6/3/2026model_release
OpenAI adds new life sciences capabilities to GPT-Rosalind
OpenAI says GPT-Rosalind now has improved biological reasoning, medicinal chemistry expertise, genomics analysis, and support for experimental workflows. The update is aimed at strengthening life sciences research use cases rather than a consumer-facing product launch.